截至2025年9月5日收盘，新开源(300109)报收于18.96元，上涨3.44%，换手率3.22%，成交量14.49万 手，成交额2.71亿元。 董秘最新回复 投资者： 请问董秘公司投资那么多医疗相关公司但是从公司业绩和发展方向看这些投资基本上不盈利 而且长期亏损，坊间传闻公司创业团队也是因为这些投资四分五裂内斗不断，pvp精细化工固态电池发 展方向前景可观，公司有没有考虑择除那些没有盈利公司提高公司盈利水平，另外公司参股公司的抗癌 相关产品属于创新药现在进展如何？ 来自交易信息汇总：9月5日主力资金净流出1250.82万元，散户资金净流入878.95万元。 交易信息汇总 资金流向 9月5日主力资金净流出1250.82万元；游资资金净流入371.86万元；散户资金净流入878.95万元。 投资者： 尊敬的董秘，你好，有几个问题想请教一下：1、24年公司年报中提到，公司参股公司新药爱 可伦已经提交上市申请，25年半年报中未提及该项目进展，请问目前上市申请进展如何？2、公司上半 年收入在下降的基础上，营业成本确大幅增长，请问是什么原因？3、目前pvp行业价格是否趋于稳定？ 与巴斯夫等国际竞争对手相比，公司的优 ...

腾讯混元宣布将旗下国际翻译模型开源，供开发者免费下载部署。据了解，这一模型命名为Hunyuan- MT-7B，总参数量仅7B，支持33个语种、5种民汉语言/方言互译，是一个能力全面的轻量级翻译模型。 ...

Market Performance - The chemical products sector increased by 0.37% on September 1, with *ST Jintai leading the gains [1] - The Shanghai Composite Index closed at 3875.53, up 0.46%, while the Shenzhen Component Index closed at 12828.95, up 1.05% [1] Top Gainers in Chemical Sector - *ST Quantai (300225) closed at 5.79, up 12.21% with a trading volume of 366,800 shares and a turnover of 204 million yuan [1] - Kangda New Materials (002669) closed at 15.46, up 10.04% with a trading volume of 305,700 shares [1] - Jianye Co. (603948) closed at 32.09, up 10.01% with a trading volume of 25,800 shares [1] - Dinglong Technology (603004) closed at 24.42, up 10.00% with a trading volume of 78,100 shares [1] - Zanyu Technology (002637) closed at 12.02, up 9.97% with a trading volume of 154,400 shares [1] Top Losers in Chemical Sector - Akole (603722) closed at 51.95, down 7.99% with a trading volume of 75,000 shares and a turnover of 392 million yuan [2] - Jiabiyou (688089) closed at 27.36, down 5.07% with a trading volume of 122,100 shares [2] - Andyshi (66ZOO9) closed at 10.07, down 4.82% with a trading volume of 271,400 shares [2] Capital Flow Analysis - The chemical products sector experienced a net outflow of 361 million yuan from institutional investors, while retail investors saw a net inflow of 243 million yuan [2][3] - Kangda New Materials (002669) had a net inflow of 1.21 billion yuan from institutional investors, but a net outflow of 55.12 million yuan from retail investors [3] - Zanyu Technology (002637) had a net inflow of 61.87 million yuan from institutional investors, with a net outflow of 32.00 million yuan from retail investors [3]

每经AI快讯，9月1日，新开源（300109）公告，公司副总经理邹晓文计划减持股份。邹晓文目前持有 公司500,928股，占总股本的0.10%。根据减持计划，其拟于2025年9月22日至2025年12月21日期间，通 过集中竞价交易方式减持不超过125,232股，占公司总股本比例不超过0.03%。 ...

资料显示，博爱新开源医疗科技集团股份有限公司位于河南省焦作市博爱县文化路(东段)1888号，成立 日期2003年3月13日，上市日期2010年8月25日，公司主营业务涉及PVP系列产品、PVME/MA等高附加 值药用辅料、功能性高分子聚合物的研发、生产和销售;肿瘤早期诊断、分子诊断、基因测序等体外诊 断服务。主营业务收入构成为：PVP系列其他41.90%，PVPK3030.64%，欧瑞姿系列11.39%，PVP- I6.44%，基因检测技术服务2.61%，肿瘤早期诊断2.56%，精准医疗服务2.53%，分子诊断服务1.93%。 截至8月20日，新开源股东户数2.22万，较上期增加1.37%；人均流通股20262股，较上期减少1.35%。 2025年1月-6月，新开源实现营业收入6.44亿元，同比减少12.36%；归母净利润1.39亿元，同比减少 34.74%。 8月29日，新开源涨0.58%，成交额4.11亿元。两融数据显示，当日新开源获融资买入额6700.01万元， 融资偿还5353.38万元，融资净买入1346.62万元。截至8月29日，新开源融资融券余额合计7.72亿元。 融资方面，新开源当日融资买入6 ...

格隆汇8月29日丨新开源(300109.SZ)公布，截至公告日持有公司股份500,928股(占本公司总股本比例 0.10%)的高级管理人员邹晓文先生计划在公告披露之日起15个交易日后的3个月内(2025年9月22日至 2025年12月21日，但窗口期不减持)以集中竞价交易方式减持公司股份不超过(含)125,232股(占公司总股 本的比例不超过0.03%)。 ...

Summary of Key Points Core Viewpoint - On August 29, Guizhou Moutai announced plans for a significant share buyback, while 13 other listed companies disclosed their intentions to reduce shareholdings [1][2]. Group 1: Guizhou Moutai - The controlling shareholder of Guizhou Moutai intends to increase its stake by purchasing shares worth between 3 billion to 3.3 billion yuan [2]. Group 2: Companies Reducing Holdings - Several companies announced share reductions, including: - Siyi Information: Five actual controllers plan to reduce their holdings by up to 3% [2]. - Galaxy Magnetics: Director He Jinzhu plans to sell no more than 460,000 shares [2]. - Pinwo Food: The controlling shareholder Wang Mu intends to reduce his stake by up to 3% [2]. - Dike Co., Ltd.: Shareholders from Wuxi Diyin Technology, Wuxi Saide Technology, and Wuxi Shanghui Jia plan to reduce their holdings by up to 1% [2]. - Hengguang Co., Ltd.: Shareholder Xiangjiang Investment plans to reduce its stake by up to 2.99% [2]. - New Open Source: Deputy General Manager Zou Xiaowen plans to sell no more than 125,200 shares [2]. - Nawei Technology: Shareholders intend to reduce their holdings by up to 2.6759% [2]. - Aojing Medical: Shareholders plan to reduce their stake by up to 1% [2]. - Huasheng Tiancai: Director Wang Weihang and Supervisor Qian Jiying plan to reduce their holdings by up to 0.9984% [2]. - Kosen Technology: Director Tan Chai Hau plans to reduce his stake by up to 0.0615% [2]. - Aorite: Tian Tai Bolong plans to reduce its holdings by up to 0.54% [2]. - Zhejiang Wen Film: Shareholder Qian Wenlong plans to reduce his stake by up to 0.4308% [2]. - Chenxin Pharmaceutical: Shareholder Shi Sihua plans to reduce his holdings by up to 1% [2].

Summary of Key Points Core Viewpoint - On August 29, 2023, Guizhou Moutai announced plans for significant stock buybacks, while 13 other listed companies disclosed their intentions to reduce shareholdings, indicating a mixed sentiment in the market regarding stock ownership adjustments [1][2]. Group 1: Stock Buybacks - Guizhou Moutai's controlling shareholder intends to increase their stake by purchasing between 3 billion to 3.3 billion yuan worth of company shares [2]. Group 2: Stock Reductions - Several companies announced share reductions, including: - Sayi Information: Five actual controllers plan to reduce their holdings by up to 3% [2]. - Galaxy Magnetics: Director He Jinzhu plans to sell no more than 460,000 shares [2]. - Pinwo Food: The controlling shareholder Wang Mu intends to reduce his stake by up to 3% [2]. - Dike Co., Ltd.: Shareholders from Wuxi Diyin Technology, Wuxi Saide Technology, and Wuxi Shanghui Jia plan to reduce their holdings by up to 1% [2]. - Hengguang Co., Ltd.: Shareholder Xiangjiang Investment plans to reduce holdings by up to 2.99% [2]. - New Open Source: Deputy General Manager Zou Xiaowen plans to sell no more than 125,200 shares [2]. - Nawei Technology: Shareholders intend to reduce their holdings by up to 2.6759% [2]. - Aojing Medical: Shareholders plan to reduce their holdings by up to 1% [2]. - Huasheng Tiancai: Director Wang Weihang and Supervisor Qian Jiying plan to reduce their holdings by up to 0.9984% [2]. - Kosen Technology: Director Tan Chai Hau plans to reduce holdings by up to 0.0615% [2]. - Aoyue Technology: Tian Tai Bolong plans to reduce holdings by up to 0.54% [2]. - Zhejiang Wen Film: Shareholder Qian Wenlong plans to reduce holdings by up to 0.4308% [2]. - Chenxin Pharmaceutical: Shareholder Shi Sihua plans to reduce holdings by up to 1% [2].

Core Points - The announcement reveals a share reduction plan by the company's senior management, specifically by Zou Xiaowen, who holds 500,928 shares, representing 0.10% of the total share capital [1] - Zou plans to reduce up to 125,232 shares, which is no more than 0.03% of the total share capital, due to personal financial needs, within a specified trading window [1] - The reduction will occur through centralized bidding transactions and will be adjusted if there are any corporate actions affecting share capital during the reduction period [1] Regulatory Compliance - The share reduction plan complies with relevant laws and regulations, including the Securities Law and the Shenzhen Stock Exchange's rules, and does not violate Zou's previous share lock-up commitments [2] - The company will adhere to legal obligations and internal regulations during the reduction period, ensuring timely information disclosure [2] - As Zou is not a controlling shareholder, the implementation of this reduction plan will not lead to any change in the company's control [2]

证券代码：300109 证券简称：新开源 公告编号：2025-034 博爱新开源医疗科技集团股份有限公司 关于部分高级管理人员股份减持计划的预披露公告 高级管理人员邹晓文先生保证向本公司提供的信息内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： | | 减持原 | 减持 | 股份来 | 计划减持股 | 占公司总 | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 股东名称 | | | | 份数量不超 | 股本的比 | 减持价格 | 减持期间 | | | 因 | 方式 | 源 | | | | | | | | | | 过（股） | 例（%） | | | | | | | 非公开 | | | | 自公告日起 15 个 交易日后的 3 个 | | --- | --- | --- | --- | --- | --- | --- | --- | | | 个人资 | 集中 | 发行、股 | | | 根据减持时 | 月内实施（2025 | | 邹晓文 | 金需求 | 竞价 ...